About
Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark.
Annual results
Reported figures, USD · revenue up 16.3% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 3.7B | 963M | 25.9% | — |
| 2024 | 3.2B | 1.2B | 36.4% | — |
| 2023 | 2.4B | 646M | 26.4% | — |
| 2022 | 2.2B | 810M | 37.6% | — |
| 2021 | 1.3B | 439M | 34.8% | — |
GMAB.CO in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Genmab A/S are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.